SinoMab BioScience (688117.SH): The application for approval of the raw material of oxytocin has been granted.

"Zhixun Finance APP - Shengno Biotechnology (688117.SH) announced that the company's wholly-owned subsidiary, Chengdu Shengno Biopharmaceutical Co., Ltd., recently received the 'Approval Notice for the Application for Marketing of Chemical Raw Materials of Oxytocin' issued by the National Medical Products Administration."